Evidence linking alcohol to cancer has accumulated for years, yet less than half of Americans recognize it as a cancer risk factor ...

Participation in the 340B Drug Pricing Program does not increase the use of targeted therapy in older patients with advanced prostate cancer, a study suggests.

Modest absolute reduction in use observed, which increased during peak of shortage; no difference seen in mortality during shortage ...

(HealthDay News) — Exposure to nonsteroidal anti-inflammatory drugs (NSAIDs) during pregnancy is associated with an increased risk for childhood chronic kidney disease (CHD), although the association ...

Prostate-specific membrane antigen-positron emission tomography (PSMA-PET) frequently detects metastatic disease missed by conventional imaging, investigators report.

Seasonal influenza vaccination, but not COVID-19 vaccination, in patients with acute heart failure is associated with less severe decompensation.

“Mortality prediction models for people with kidney failure can support patient-clinician discussions at a crucial point where decisions are made about treatment options, including long-term kidney ...

(HealthDay News) — Racial and ethnic disparities are seen in the use of obesity-management medications, according to a study published online in the Journal of Racial and Ethnic Health Disparities.

The FDA has issued a CRL to Lexicon regarding the NDA for Zynquista (sotagliflozin) as an adjunct to insulin therapy for T1D and CKD.

The FDA has approved Opdivo Qvantig (nivolumab and hyaluronidase-nvhy), a new subcutaneous injection formulation of Opdivo.

Intensive blood pressure control in hypertensive chronic kidney disease (CKD) provides a survival advantage and other benefits.

Acellular tissue-engineered vessel is approved for use in adults as a vascular conduit for extremity arterial injury ...